United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 8, 2026 · Filed Jun 9, 2026

On Jun 8, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$547.49 for US$5.2M under a trading plan, leaving 40,513 shares. Filed Jun 9, 2026 (Form 4).

Sold
9,500 shares
Price
US$547.49 average (US$544.89 to US$551.37)
Value
US$5.2M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 8, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 8, 2026Common StockSale1,462US$544.8948,551Direct
Jun 8, 2026Common StockSale2,131US$546.1346,420Direct
Jun 8, 2026Common StockSale1,525US$547.0744,895Direct
Jun 8, 2026Common StockSale2,144US$547.9342,751Direct
Jun 8, 2026Common StockSale948US$549.5841,803Direct
Jun 8, 2026Common StockSale650US$550.4041,153Direct
Jun 8, 2026Common StockSale640US$551.3740,513Direct

Source

View original at SEC

Related